Analysts’ Updated EPS Estimates for May 4th (ACCO, ACHC, ACIU, AME, AMZN, APEI, ARTV, ASMB, AVXL, AZN)

Analysts’ updated eps estimates for Monday, May 4th:

Acco Brands (NYSE:ACCO) had its outperform rating reiterated by analysts at Barrington Research. The firm currently has a $5.00 target price on the stock.

Acadia Healthcare (NASDAQ:ACHC) was upgraded by analysts at Raymond James Financial, Inc. from an outperform rating to a strong-buy rating. Raymond James Financial, Inc. currently has $39.00 price target on the stock.

AC Immune (NASDAQ:ACIU) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $8.00 price target on the stock.

AMETEK (NYSE:AME) had its buy rating reaffirmed by analysts at DA Davidson. The firm currently has a $265.00 target price on the stock.

Amazon.com (NASDAQ:AMZN) had its buy rating reiterated by analysts at Jefferies Financial Group Inc..

American Public Education (NASDAQ:APEI) had its outperform rating reissued by analysts at Barrington Research. Barrington Research currently has a $56.00 target price on the stock.

Artiva Biotherapeutics (NASDAQ:ARTV) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $18.00 target price on the stock.

Assembly Biosciences (NASDAQ:ASMB) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $50.00 price target on the stock.

Rodman & Renshaw started coverage on shares of Anavex Life Sciences (NASDAQ:AVXL). Rodman & Renshaw issued a buy rating and a $20.00 target price on the stock.

Astrazeneca (NYSE:AZN) had its buy rating reiterated by analysts at Sanford C. Bernstein.

Banner (NASDAQ:BANR) had its neutral rating reaffirmed by analysts at DA Davidson. The firm currently has a $72.00 price target on the stock.

Evercore Inc initiated coverage on shares of Becton, Dickinson and Company (NYSE:BDX). The firm issued an outperform rating and a $180.00 target price on the stock.

Needham & Company LLC initiated coverage on shares of Better Home & Finance (NASDAQ:BETR). Needham & Company LLC issued a buy rating and a $53.00 target price on the stock.

Cabaletta Bio (NASDAQ:CABA) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $30.00 price target on the stock.

Cullinan Therapeutics (NASDAQ:CGEM) had its buy rating reissued by analysts at BTIG Research. They currently have a $38.00 target price on the stock.

Church & Dwight (NYSE:CHD) had its outperform rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $114.00 target price on the stock, up from their previous target price of $112.00.

Colgate-Palmolive (NYSE:CL) had its outperform rating reiterated by analysts at Royal Bank Of Canada. They currently have a $102.00 price target on the stock.

Clene (NASDAQ:CLNN) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $31.00 target price on the stock.

Clene (NASDAQ:CLNN) had its buy rating reiterated by analysts at D. Boral Capital. The firm currently has a $23.00 target price on the stock.

CNH Industrial (NYSE:CNH) had its neutral rating reissued by analysts at DA Davidson. DA Davidson currently has a $12.00 price target on the stock.

Cinemark (NYSE:CNK) had its outperform rating reiterated by analysts at Barrington Research. The firm currently has a $36.00 target price on the stock.

Coty (NYSE:COTY) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a $8.00 price target on the stock.

CubeSmart (NYSE:CUBE) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a $46.00 target price on the stock.

Commercial Vehicle Group (NASDAQ:CVGI) had its outperform rating reissued by analysts at Barrington Research. Barrington Research currently has a $6.00 price target on the stock.

Dave (NASDAQ:DAVE) had its outperform rating reissued by analysts at Barrington Research. The firm currently has a $290.00 target price on the stock.

Diebold Nixdorf (NYSE:DBD) had its buy rating reaffirmed by analysts at DA Davidson. They currently have a $100.00 target price on the stock.

DBV Technologies (NASDAQ:DBVT) had its buy rating reaffirmed by analysts at Guggenheim. Guggenheim currently has a $51.00 price target on the stock.

Datadog (NASDAQ:DDOG) had its buy rating reaffirmed by analysts at DA Davidson. They currently have a $225.00 price target on the stock.

DHI Group (NYSE:DHX) had its outperform rating reiterated by analysts at Barrington Research. The firm currently has a $10.00 target price on the stock.

Dorman Products (NASDAQ:DORM) had its outperform rating reiterated by analysts at Barrington Research. They currently have a $150.00 price target on the stock.

Eupraxia Pharmaceuticals (NASDAQ:EPRX) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $11.00 price target on the stock.

FibroBiologics (NASDAQ:FBLG) had its hold rating reaffirmed by analysts at Maxim Group.

Fifth Third Bancorp (NASDAQ:FITB) had its outperform rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $57.00 price target on the stock.

GlobalFoundries (NASDAQ:GFS) had its neutral rating reaffirmed by analysts at Wedbush. The firm currently has a $50.00 price target on the stock.

Galaxy Digital (NASDAQ:GLXY) had its buy rating reiterated by analysts at Chardan Capital. Chardan Capital currently has a $35.00 price target on the stock.

Alphabet (NASDAQ:GOOGL) had its buy rating reiterated by analysts at Jefferies Financial Group Inc..

Alphabet (NASDAQ:GOOGL) had its buy rating reissued by analysts at JPMorgan Chase & Co..

Hubbell (NYSE:HUBB) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Huron Consulting Group (NASDAQ:HURN) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Incyte (NASDAQ:INCY) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $135.00 target price on the stock.

Intel (NASDAQ:INTC) had its neutral rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $80.00 target price on the stock.

IonQ (NYSE:IONQ) had its outperform rating reissued by analysts at Wedbush. The firm currently has a $60.00 target price on the stock.

JPMorgan Chase & Co. (NYSE:JPM) had its neutral rating reissued by analysts at Jefferies Financial Group Inc..

Kadant (NYSE:KAI) had its outperform rating reaffirmed by analysts at Barrington Research. Barrington Research currently has a $380.00 target price on the stock.

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) was upgraded by analysts at Wall Street Zen from a hold rating to a strong-buy rating.

Koppers (NYSE:KOP) had its outperform rating reissued by analysts at Barrington Research. Barrington Research currently has a $55.00 target price on the stock.

Krystal Biotech (NASDAQ:KRYS) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $310.00 target price on the stock.

Lucid Group (NASDAQ:LCID) had its neutral rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $14.00 price target on the stock.

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) had its buy rating reissued by analysts at D. Boral Capital. D. Boral Capital currently has a $3.00 target price on the stock.

LifeMD (NASDAQ:LFMD) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $10.00 price target on the stock.

Eli Lilly and Company (NYSE:LLY) had its outperform rating reiterated by analysts at Wolfe Research. The firm currently has a $1,325.00 price target on the stock.

Liquidity Services (NASDAQ:LQDT) had its outperform rating reiterated by analysts at Barrington Research. They currently have a $44.00 target price on the stock.

Marcus (NYSE:MCS) had its outperform rating reissued by analysts at Barrington Research. They currently have a $25.00 price target on the stock.

MediciNova (NASDAQ:MNOV) had its buy rating reiterated by analysts at D. Boral Capital. They currently have a $9.00 target price on the stock.

Microsoft (NASDAQ:MSFT) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc..

ServiceNow (NYSE:NOW) had its buy rating reiterated by analysts at BTIG Research. The firm currently has a $150.00 price target on the stock.

Packaging Corporation of America (NYSE:PKG) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a hold rating to a buy rating. The firm currently has $256.00 price target on the stock, up from their previous price target of $225.00.

Stephens initiated coverage on shares of Porch Group (NASDAQ:PRCH). They issued an overweight rating and a $12.00 price target on the stock.

D. Boral Capital started coverage on shares of Prelude Therapeutics (NASDAQ:PRLD). The firm issued a buy rating and a $9.00 price target on the stock.

Prudential Financial (NYSE:PRU) had its underweight rating reissued by analysts at Morgan Stanley. Morgan Stanley currently has a $92.00 target price on the stock, down from their previous target price of $106.00.

Q2 (NYSE:QTWO) had its buy rating reaffirmed by analysts at DA Davidson. They currently have a $82.00 target price on the stock.

Saia (NASDAQ:SAIA) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Shenandoah Telecommunications (NASDAQ:SHEN) had its buy rating reissued by analysts at BWS Financial. BWS Financial currently has a $26.00 target price on the stock.

SiteOne Landscape Supply (NYSE:SITE) was upgraded by analysts at Stifel Nicolaus from a hold rating to a buy rating. They currently have $157.00 price target on the stock.

Standex International (NYSE:SXI) had its buy rating reiterated by analysts at DA Davidson. DA Davidson currently has a $323.00 target price on the stock.

Tarsus Pharmaceuticals (NASDAQ:TARS) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $88.00 target price on the stock.

Toronto Dominion Bank (NYSE:TD) (TSE:TD) was upgraded by analysts at Scotiabank from a sector perform rating to a sector outperform rating.

Targa Resources (NYSE:TRGP) had its neutral rating reaffirmed by analysts at Seaport Research Partners.

Tyler Technologies (NYSE:TYL) had its buy rating reaffirmed by analysts at DA Davidson. The firm currently has a $460.00 price target on the stock.

Vital Farms (NASDAQ:VITL) had its neutral rating reaffirmed by analysts at DA Davidson. The firm currently has a $16.00 target price on the stock, down from their previous target price of $47.00.

Weyerhaeuser (NYSE:WY) had its buy rating reaffirmed by analysts at DA Davidson. The firm currently has a $31.00 price target on the stock.